Novel HDAC inhibitor, targeting HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, and HDAC9

Novel Histone deacetylase (HDAC) inhibotor, displays potent inhibitory activity towards human HDACs and several cancer cells lines

Novel inhibitor of scavenger receptor BI (SR-BI)

Potent antifungal agent, hosting defense peptide mimic through a membrane-active mechanism

Potent inhibitor of the ErbB receptor family (IC50 values are 0.3, 0.5 and 1.1 nM for ErbB1 (EGFR), ErbB4 and ErbB2 respectively)

Anti-inflammatory and anti-cancer agent, disrupting the cooperation of CCAAT-box/enhancer-binding protein beta (C/EBPß) and co-activator p300

Natural anti-inflammatory and anti-cancer agent

Inhibitor of interleukin-1β-induced MIP-1β production

Cytotoxic peptide, inducing mitotic arrest and abnormal spindle formation

The biosynthetic precursor of gossypol

Heparan sulfate antagonist

Heparin derivative for treatment of thrombotic diseases

Master regulator of iron homeostasis, contributing to Swedish mutant APP-induced osteoclastogenesis and trabecular bone loss

Novel inhibitor of Tau aggregation against Tau-related neurodegenerative diseases including Alzheimer's disease (AD)

Novel LsrK inhibitor (ID 50 119 μM) agaist antimicrobial resistance (AMR)

Novel TGF-β Signaling Inhibitor

Novel orally bioavailable, non-peptide thrombopoietin (TPO) receptor agonist

Novel inhibitor of the phosphorylation of DRP1, stimulating a phenotype suggestive of respiration through mitochondrial normalization and demonstrating activity in Vemurafenib-resistant melanoma in vivo

Novel potent inducer of hexamethylene bis-acetamide inducible protein 1 (HEXIM1)

Potent inducer of oxidative stress as well as cell cycle arrest in the S-phase, significantly decreasing intracellular ATP level

Insulin-regulated aminopeptidase (IRAP) inhibitor, mprovin memory in control and memory-deficient mice models

Novel type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases